EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer

The epidermal growth factor receptor (EGFR) signalling is regulated at multiple levels. Here the authors show that the importin RanBP6 acts as a tumor suppressor in Glioblastoma and  regulates EGFR signalling through promoting translocation of STAT3 to the nuclei and repressing EGFR transcription.

Guardado en:
Detalles Bibliográficos
Autores principales: Barbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument-Bromage, Paolo Codega, Maria Stella Carro, Alvaro Curiel-García, Carl Campos, Maryam Pourmaleki, Christian Grommes, Igor Vivanco, Daniel Rohle, Craig M. Bielski, Barry S. Taylor, Travis J. Hollmann, Marc Rosenblum, Paul Tempst, John Blenis, Massimo Squatrito, Ingo K. Mellinghoff
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/015fa09cb6784ac18a7db7bbdca85e1c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:015fa09cb6784ac18a7db7bbdca85e1c
record_format dspace
spelling oai:doaj.org-article:015fa09cb6784ac18a7db7bbdca85e1c2021-12-02T17:01:18ZEGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer10.1038/s41467-017-02185-w2041-1723https://doaj.org/article/015fa09cb6784ac18a7db7bbdca85e1c2017-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-02185-whttps://doaj.org/toc/2041-1723The epidermal growth factor receptor (EGFR) signalling is regulated at multiple levels. Here the authors show that the importin RanBP6 acts as a tumor suppressor in Glioblastoma and  regulates EGFR signalling through promoting translocation of STAT3 to the nuclei and repressing EGFR transcription.Barbara OldriniWan-Ying HsiehHediye Erdjument-BromagePaolo CodegaMaria Stella CarroAlvaro Curiel-GarcíaCarl CamposMaryam PourmalekiChristian GrommesIgor VivancoDaniel RohleCraig M. BielskiBarry S. TaylorTravis J. HollmannMarc RosenblumPaul TempstJohn BlenisMassimo SquatritoIngo K. MellinghoffNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Barbara Oldrini
Wan-Ying Hsieh
Hediye Erdjument-Bromage
Paolo Codega
Maria Stella Carro
Alvaro Curiel-García
Carl Campos
Maryam Pourmaleki
Christian Grommes
Igor Vivanco
Daniel Rohle
Craig M. Bielski
Barry S. Taylor
Travis J. Hollmann
Marc Rosenblum
Paul Tempst
John Blenis
Massimo Squatrito
Ingo K. Mellinghoff
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
description The epidermal growth factor receptor (EGFR) signalling is regulated at multiple levels. Here the authors show that the importin RanBP6 acts as a tumor suppressor in Glioblastoma and  regulates EGFR signalling through promoting translocation of STAT3 to the nuclei and repressing EGFR transcription.
format article
author Barbara Oldrini
Wan-Ying Hsieh
Hediye Erdjument-Bromage
Paolo Codega
Maria Stella Carro
Alvaro Curiel-García
Carl Campos
Maryam Pourmaleki
Christian Grommes
Igor Vivanco
Daniel Rohle
Craig M. Bielski
Barry S. Taylor
Travis J. Hollmann
Marc Rosenblum
Paul Tempst
John Blenis
Massimo Squatrito
Ingo K. Mellinghoff
author_facet Barbara Oldrini
Wan-Ying Hsieh
Hediye Erdjument-Bromage
Paolo Codega
Maria Stella Carro
Alvaro Curiel-García
Carl Campos
Maryam Pourmaleki
Christian Grommes
Igor Vivanco
Daniel Rohle
Craig M. Bielski
Barry S. Taylor
Travis J. Hollmann
Marc Rosenblum
Paul Tempst
John Blenis
Massimo Squatrito
Ingo K. Mellinghoff
author_sort Barbara Oldrini
title EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
title_short EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
title_full EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
title_fullStr EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
title_full_unstemmed EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
title_sort egfr feedback-inhibition by ran-binding protein 6 is disrupted in cancer
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/015fa09cb6784ac18a7db7bbdca85e1c
work_keys_str_mv AT barbaraoldrini egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT wanyinghsieh egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT hediyeerdjumentbromage egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT paolocodega egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT mariastellacarro egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT alvarocurielgarcia egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT carlcampos egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT maryampourmaleki egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT christiangrommes egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT igorvivanco egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT danielrohle egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT craigmbielski egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT barrystaylor egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT travisjhollmann egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT marcrosenblum egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT paultempst egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT johnblenis egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT massimosquatrito egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
AT ingokmellinghoff egfrfeedbackinhibitionbyranbindingprotein6isdisruptedincancer
_version_ 1718382126735294464